BE1001235A4 - Nouveaux derives azoliques, leur preparation et leur utilisation comme medicaments. - Google Patents

Nouveaux derives azoliques, leur preparation et leur utilisation comme medicaments. Download PDF

Info

Publication number
BE1001235A4
BE1001235A4 BE8701375A BE8701375A BE1001235A4 BE 1001235 A4 BE1001235 A4 BE 1001235A4 BE 8701375 A BE8701375 A BE 8701375A BE 8701375 A BE8701375 A BE 8701375A BE 1001235 A4 BE1001235 A4 BE 1001235A4
Authority
BE
Belgium
Prior art keywords
sep
formula
phenyl
residue
azole derivatives
Prior art date
Application number
BE8701375A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1001235A4 publication Critical patent/BE1001235A4/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE8701375A 1986-12-03 1987-12-02 Nouveaux derives azoliques, leur preparation et leur utilisation comme medicaments. BE1001235A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3641320 1986-12-03

Publications (1)

Publication Number Publication Date
BE1001235A4 true BE1001235A4 (fr) 1989-08-29

Family

ID=6315380

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8701375A BE1001235A4 (fr) 1986-12-03 1987-12-02 Nouveaux derives azoliques, leur preparation et leur utilisation comme medicaments.

Country Status (24)

Country Link
JP (1) JPH0678318B2 (uk)
KR (1) KR880007481A (uk)
AT (1) AT395587B (uk)
AU (1) AU605522B2 (uk)
BE (1) BE1001235A4 (uk)
CH (1) CH677925A5 (uk)
DK (1) DK631287A (uk)
ES (1) ES2010235A6 (uk)
FI (1) FI875300A (uk)
FR (1) FR2607810B1 (uk)
GB (1) GB2199579B (uk)
GR (1) GR871897B (uk)
HU (1) HU198694B (uk)
IL (1) IL84665A (uk)
IT (1) IT1211944B (uk)
LU (1) LU87063A1 (uk)
MY (1) MY103004A (uk)
NL (1) NL8702897A (uk)
NZ (1) NZ222765A (uk)
PH (1) PH24666A (uk)
PL (1) PL151588B1 (uk)
PT (1) PT86255B (uk)
SE (1) SE8704792L (uk)
ZA (1) ZA879093B (uk)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds
UA41295C2 (uk) * 1991-09-02 2001-09-17 Яманугі Фармасетікл Ко., Лтд Триазолілзаміщені третинні амінні сполуки або їх солі як інгібітор ароматази та фармацевтична композиція на їх основі
GB9409882D0 (en) * 1994-05-18 1994-07-06 Sandoz Ltd Organic compounds
GB0128415D0 (en) * 2001-11-27 2002-01-16 Univ Sheffield Medicaments

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239246A1 (en) * 1986-02-24 1987-09-30 Shikoku Chemicals Corporation Novel imidazole compounds, process for synthesis thereof, and method of curing epoxy resins using said compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT382868B (de) * 1983-03-11 1987-04-27 Sandoz Ag Verfahren zur herstellung neuer azolderivate und deren salze

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239246A1 (en) * 1986-02-24 1987-09-30 Shikoku Chemicals Corporation Novel imidazole compounds, process for synthesis thereof, and method of curing epoxy resins using said compounds

Also Published As

Publication number Publication date
PT86255A (en) 1988-06-01
DK631287A (da) 1988-06-04
AU605522B2 (en) 1991-01-17
IT1211944B (it) 1989-11-08
GB8727978D0 (en) 1988-01-06
PL151588B1 (en) 1990-09-28
IL84665A0 (en) 1988-05-31
PL269180A1 (en) 1988-08-18
HUT45506A (en) 1988-07-28
MY103004A (en) 1993-03-31
IL84665A (en) 1991-11-21
ES2010235A6 (es) 1989-11-01
AU8196287A (en) 1988-06-16
FR2607810B1 (fr) 1989-12-01
HU198694B (en) 1989-11-28
CH677925A5 (uk) 1991-07-15
ATA316887A (de) 1992-06-15
GB2199579B (en) 1990-07-18
FR2607810A1 (fr) 1988-06-10
PH24666A (en) 1990-09-07
GB2199579A (en) 1988-07-13
FI875300A (fi) 1988-06-04
NZ222765A (en) 1990-11-27
NL8702897A (nl) 1988-07-01
DK631287D0 (da) 1987-12-01
IT8748656A0 (it) 1987-12-01
JPS63145270A (ja) 1988-06-17
PT86255B (pt) 1990-11-07
KR880007481A (ko) 1988-08-27
FI875300A0 (fi) 1987-12-01
SE8704792D0 (sv) 1987-12-01
ZA879093B (en) 1989-07-26
LU87063A1 (fr) 1988-07-14
GR871897B (en) 1988-04-04
JPH0678318B2 (ja) 1994-10-05
AT395587B (de) 1993-01-25
SE8704792L (sv) 1988-06-04

Similar Documents

Publication Publication Date Title
EP0099802B1 (fr) Nouveaux dérivés de la thiéno-(3,2-c) pyridine, leur procédé de préparation et leur application thérapeutique
BE851310A (fr) Nouveaux derives de la tetrahydro-equinocandine b
CA2554610A1 (fr) Derives d'aryl- et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application comme inhibiteurs de l'enzyme faah
CA1190226A (fr) Procede de preparation de nouvelles pyrimido quinoxalines et de leurs sels
EP0624575A1 (fr) Indoles substitués et les compositions pharmaceutiques qui les contiennent
EP0117771B1 (fr) Imino-2 pyrrolidines, leur procédé de préparation et leurs applications en thérapeutique
EP2419422B1 (fr) Dérivés d'imidazolidine-2,4-dione et leur utilisation comme médicament
BE1001235A4 (fr) Nouveaux derives azoliques, leur preparation et leur utilisation comme medicaments.
EP0004494B1 (fr) Nouveaux dérivés de 1,3-dihydro 3-(1-(2-(2,3-dihydro 1,4-benzo-dioxin-2-yl)2-hydroxy éthyl)pipéridin-4-yl)2H-indol 2-one, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
EP0021924A2 (fr) Dérivés de l'indole, procédé pour leur préparation, leur application comme médicaments et compositions pharmaceutiques les contenant
EP1793834B1 (fr) Derives pyridiniques d ' indolin-2-one , leur preparation et leur application en therapeutique
EP0002401B1 (fr) Dérivés de naphtalène, leur préparation et leur application en thérapeutique
EP0076713B1 (fr) Nouveaux dérivés de l'aminométhyl 1H-indole 4-méthanol et leurs sels, leur procédé et les intermédiaires de préparation, leur application à titre de médicaments, les compositions les renfermant
EP0168309B1 (fr) Nouveaux dérivés de l'isoxazoloquinoléinone, procédé et intermédiaires de préparation, application à titre de médicaments, et compositions les renfermant
WO1992021664A1 (fr) Nouveaux derives de l'oxazole, leur preparation et les compositions qui les contiennent
WO1992021665A1 (fr) Nouveaux derives de l'oxazole et leur preparation
EP1674101B1 (fr) Dérivés cinnamates de benzo [b]pyrano[3,2-h]acridin-7-one, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CA2037549A1 (fr) Utilisation de composes anti-progestomimetiques chez les animaux d'elevage
CA1230128A (fr) Procede pour la preparation de derives acetyleniques possedant une activite d'inhibiteurs d'enzyme et les derives ainsi obtenus
EP0032889B1 (fr) Nouveaux dérivés du type diméthyl-1,10 oxayohimbane et médicaments les contenant
FR2600254A1 (fr) Derives methylenes des androstene-4 diones-3, 17, leur procede de preparation, et leur application comme medicaments
CH669599A5 (uk)
FR2789393A1 (fr) Lactol steroidique
BE879248A (fr) Nouvelles amines cycliques substituees, leur preparation et leur application comme medicaments
FR2617165A1 (fr) Derives du dimethyl-2, 2 chromannol-3

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19931231